LATIN AMERICA CRISPR MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

LATIN AMERICA CRISPR MARKET 2019-2028

Market By Product, Application And End-user | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research’s report on the Latin American CRISPR market illustrates that the market will augment at a CAGR of 22.37% in the forecasted years 2019-2028.



We provide additional customization based on your specific requirements. Request For Customization

The countries reviewed in the Latin American CRISPR market are:

           Mexico

           Brazil

           Rest of Latin America

In Brazil, genetically-edited crops are considered as conventional plants unless they contain any foreign DNA. According to the changes that were introduced in January 2018, it was concluded that NBTs (New Breeding Techniques) could not be regulated as transgenic GMOs (genetically modified organisms) if no genes are retained from foreign species. The National Technical Commission sets safety standards for genetically modified organisms (GMOs). Furthermore, the Brazilian company Tropical Melhoramento & Genética has collaborated with an Israeli company Evogene to develop a parasite-resistant soybean, using gene-editing tools like CRISPR (Clustered Regularly Interspaced Short Palindrome Repeats). The growing CRISPR procedures in the country are expected to drive the market during the forthcoming period.

In Mexico, human genome editing and human genetic engineering are not explicitly regulated. However, all applications of CRISPR technology must be monitored, and procedures, not safety-tested in humans must be penalized. Also, Mexico is known as a center of origin for various economically important plants, such as maize, cocoa and cotton. Crops such as soybean, maize and cotton have been genetically engineered in order to tolerate and resist insect pests and herbicides, among others. Such developmental initiatives indicate the growth of the CRISPR market in the country.

Established in 1974, New England Biolabs is a US-based company engaged in the field of discovery, development and marketing of native enzymes for genomic research. The company provides different products and services, including reagents, antibodies, enzymes and DNA controls for protein expression & purification technologies, protein tools, epigenetics research, glycobiology products & plasmids and DNAs for cloning experiments. The company is active in different regions, including Latin America.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    LATIN AMERICA CRISPR MARKET – SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. VALUE CHAIN OUTLOOK

2.4. SUPPLY CHAIN OUTLOOK

2.5. TIMELINE OF CRISPR MARKET

2.6. PARENT MARKET OUTLOOK

2.7. KEY INSIGHT

2.8. MARKET ATTRACTIVENESS INDEX

2.9. MARKET DRIVERS

2.9.1.   GROWING LIFESTYLE-ORIENTED DISEASES

2.9.2.   SURGING PREVALENCE OF GENETIC DISEASES

2.9.3.   INCREASING APPLICATION OF DRUGS

2.9.4.   RISING AGING POPULATION

2.9.5.   INCIDENCE OF GENETIC AILMENTS

2.10. MARKET RESTRAINTS

2.10.1. ETHICAL AND SOCIAL ISSUES ASSOCIATED WITH CRISPR TECHNOLOGY

2.10.2. CHANGING REGULATORY ENVIRONMENT

2.11. MARKET OPPORTUNITIES

2.11.1. INCREASED DEMAND FOR CRISPR  

2.11.2. ADVANCEMENTS IN THE APPLICATIONS OF GENE-BASED THERAPY

2.12. MARKET CHALLENGES

2.12.1.  ALTERNATIVE TECHNOLOGIES

2.12.2. LACK OF AWARENESS REGARDING THE TECHNOLOGY

3.    CRISPR MARKET OUTLOOK - BY PRODUCT

3.1. PLASMIDS

3.2. VECTORS

3.3. PROTEINS

3.4. DESIGN TOOLS

3.5. GRNA

3.6. CONTROL KITS

3.7. LIBRARY

3.8. OTHER PRODUCTS

4.    CRISPR MARKET OUTLOOK - BY APPLICATION

4.1. GENOME EDITING/GENETIC ENGINEERING

4.2. GRNA DATABASE/GENE LIBRARY

4.3. CRISPR PLASMID

4.4. HUMAN STEM CELLS

4.5. CELL LINE ENGINEERING

5.    CRISPR MARKET OUTLOOK - BY END-USER

5.1. THERAPEUTICS & DRUG DISCOVERY

5.2. BIOLOGICAL RESEARCH

5.3. AGRICULTURAL BIOTECH

5.4. INDUSTRIAL BIOTECH

6.    CRISPR MARKET – LATIN AMERICA

6.1. BRAZIL

6.2. MEXICO

6.3. REST OF LATIN AMERICA

7.    COMPANY PROFILE

7.1. ADDGENE

7.2. APPLIED STEMCELL

7.3. CARIBOU BIOSCIENCES INC

7.4. CELLECTIS

7.5. CRISPR THERAPEUTICS

7.6. DIACARTA

7.7. EDITAS MEDICINE

7.8. GENECOPOEIA INC

7.9. GENEDATA AG

7.10. GENSCRIPT

7.11. HORIZON DISCOVERY LTD

7.12. INTEGRATED DNA TECHNOLOGIES INC

7.13. INTELLIA THERAPEUTICS INC

7.14. LONZA 

7.15. NEW ENGLAND BIOLABS 

7.16. ORIGENE TECHNOLOGIES INC

7.17. PRECISION BIOSCIENCES

7.18. SANGAMO THERAPEUTICS

7.19. SIGMA-ALDRICH (MERCK KGAA)

7.20. THERMO FISHER SCIENTIFIC INC

7.21. TRANSPOSAGEN BIO (HERA BIOLABS)

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        LATIN AMERICA CRISPR MARKET, 2019-2028 ($ MILLION)

TABLE 2        CHIEF CONCERNS RELATED TO GENETIC ENGINEERING

TABLE 3        LATIN AMERICA CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 4        TOOL NAMES AND THEIR PROVIDERS

TABLE 5        LATIN AMERICA CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 6        BARRIERS TO ENTRY IN THE AGRICULTURAL SEED MARKET,

TABLE 7        AGRICULTURE BIOTECH TRAITS INDUSTRY

TABLE 8        LATIN AMERICA CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 9        LATIN AMERICA CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

List of Figures

FIGURE 1      LATIN AMERICA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 2      VALUE CHAIN ANALYSIS

FIGURE 3      LATIN AMERICA CRISPR MARKET, BY PLASMIDS, 2019-2028 ($ MILLION)

FIGURE 4      LATIN AMERICA CRISPR MARKET, BY VECTORS, 2019-2028 ($ MILLION)

FIGURE 5      LATIN AMERICA CRISPR MARKET, BY PROTEINS, 2019-2028 ($ MILLION)

FIGURE 6      LATIN AMERICA CRISPR MARKET, BY DESIGN TOOLS, 2019-2028 ($ MILLION)

FIGURE 7      LATIN AMERICA CRISPR MARKET, BY GRNA, 2019-2028 ($ MILLION)

FIGURE 8      LATIN AMERICA CRISPR MARKET, BY CONTROL KITS, 2019-2028 ($ MILLION)

FIGURE 9      LATIN AMERICA CRISPR MARKET, BY LIBRARY, 2019-2028 ($ MILLION)

FIGURE 10   LATIN AMERICA CRISPR MARKET, BY OTHER PRODUCTS, 2019-2028 ($ MILLION)

FIGURE 11   LATIN AMERICA CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 12   LATIN AMERICA CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2019-2028 ($ MILLION)

FIGURE 13   LATIN AMERICA CRISPR MARKET, BY CRISPR PLASMID, 2019-2028 ($ MILLION)

FIGURE 14   LATIN AMERICA CRISPR MARKET, BY HUMAN STEM CELLS, 2019-2028 ($ MILLION)

FIGURE 15   LATIN AMERICA CRISPR MARKET, BY CELL LINE ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 16   LATIN AMERICA CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2019-2028 ($ MILLION)

FIGURE 17   LATIN AMERICA CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2019-2028 ($ MILLION)

FIGURE 18   LATIN AMERICA CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 19   LATIN AMERICA CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 20   LATIN AMERICA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 21   BRAZIL CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 22   MEXICO CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 23   REST OF LATIN AMERICA CRISPR MARKET, 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;